HOME PITCHING SESSION Guiding documents Timetable and how it works Agenda of pitching session Presentations on 30th July 2026

Horizon Europe Partnering Event for Ukraine, Baltics, Poland, Canada and United Kingdom

30 July 2026 - 31 December 2026

Registration open until 31 Dec 2026

182

Registered participants

174

Participants in matchmaking

Booked meetings

1129

Exchanged messages

1672

Profile views

About the Event

Building Health and Cancer Mission Consortia for 2027 calls

Estonian Research Council in cooperation with Horizon Europe Office in Ukraine, Latvian Council of Science, Research Council of Lithuania, Polish National Centre for Research and Development, Canadian Institutes of Health Research and the UK Research and Innovation — together with their National Contact Points — invite you to an international matchmaking event dedicated to building strong Horizon Europe consortia.

The event takes place on-line on 30 July 2026 on the B2Match Platform. It brings together researchers, innovators, companies, and policy stakeholders working at the forefront of these fields to exchange ideas, forge partnerships, and lay the groundwork for competitive European research consortia.

🤝

Connect with potential consortium partners who bring complementary expertise to your work.

🎯

Gain concise, call-specific insights directly relevant to Horizon Europe 2027 opportunities.

💡

Test and refine your project ideas in a trusted, expert-driven environment.

Topics Covered at the Event

The event is structured around:

13 Horizon Europe 2027 Cluster Health calls

4 Cancer Mission 2027 calls

Horizon Europe Calls in Focus

The event is built around the following open calls from the Horizon Europe 2027 Work Programme:

HORIZON-HLTH-2027-01-STAYHLTH-01

Addressing disabilities through the life course to support independent living and inclusion (RIA)The call opens on 10th February 2026

HORIZON-HLTH-2027-01-ENVHLTH-02

Integrating climate-related exposures into the human exposome and characterising its changes in response to climate change (RIA)

HORIZON-HLTH-2027-02-DISEASE-01-two-stage

Innovative healthcare interventions for non-communicable diseases (RIA)

HORIZON-HLTH-2027-01-DISEASE-05

Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential (RIA)

HORIZON-HLTH-2027-01-DISEASE-06

Development of monoclonal antibodies to prevent and treat infections from Flaviviruses (RIA)

HORIZON-HLTH-2027-01-DISEASE-07

Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga viruses (RIA)

HORIZON-HLTH-2027-01-DISEASE-08

Development of innovative antimicrobials against pathogens resistant to antimicrobials (RIA)

HORIZON-HLTH-2027-02-DISEASE-14-two-stage

Clinical trials for advancing innovative interventions for neurodegenerative diseases (RIA)

HORIZON-HLTH-2027-01-CARE-02

Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications (RIA)

HORIZON-HLTH-2027-02-TOOL-01-two-stage

Development of predicitve biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases (RIA)

HORIZON-HLTH-2027-03-TOOL-04

Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis (RIA)

HORIZON-HLTH-2027-01-IND-01

Development of cell-free protein synthesis platforms for discovery and/or production of biologicals (RIA)

HORIZON-HLTH-2027-02-IND-02-two-stage

Portable and versatile Point-of-care diagnostics (IA)

HORIZON-MISS-2027-02-CANCER-01

Leveraging functional genomics to reveal novel targets for cancer treatment (RIA)

HORIZON-MISS-2027-02-CANCER-02

Clinical research by Comprehensive Cancer Infrastructures for the benefit of patients with common cancers (IA)

HORIZON-MISS-2027-02-CANCER-03

Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes (RIA)

HORIZON-MISS-2027-02-CANCER-04

Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes research (RIA)